Advertisement

Readers like you keep news free for everyone.

More than 5,000 readers have already pitched in to keep free access to The Journal.

For the price of one cup of coffee each week you can help keep paywalls away.

Support us today
Not now
Friday 22 September 2023 Dublin: 9°C
Alamy Stock Photo Demonstrators from opposing sides of the abortion debate speak outside the US Supreme Court in Washington, DC.
# mifepristone
US Supreme Court preserves women's access to abortion drug
The drug has been approved for use in the US since 2000.

THE US SUPREME Court has preserved women’s access to a drug used in the most common method of abortion, rejecting lower-court restrictions while a lawsuit continues.

Yesterday the justices granted emergency requests from the Biden administration and New York-based Danco Laboratories, maker of the drug mifepristone.

They are appealing a lower court ruling that would roll back Food and Drug Administration approval of mifepristone.

The drug has been approved for use in the US since 2000 and more than five million people have used it.

Mifepristone is used in combination with a second drug, misoprostol, in more than half of all abortions in the US.

President Joe Biden praised the high court for keeping mifepristone available while the court fight continues.

“The stakes could not be higher for women across America. I will continue to fight politically-driven attacks on women’s health,” Mr Biden said in a statement.

“But let’s be clear – the American people must continue to use their vote as their voice, and elect a Congress who will pass a law restoring the protections of Roe v Wade.”

Author
Press Association
Your Voice
Readers Comments
35
This is YOUR comments community. Stay civil, stay constructive, stay on topic. Please familiarise yourself with our comments policy here before taking part.
Leave a Comment
    Submit a report
    Please help us understand how this comment violates our community guidelines.
    Thank you for the feedback
    Your feedback has been sent to our team for review.

    Leave a commentcancel